Yabao Pharmaceutical Group
4 clinical trials · Sponsor
◉ Watch Yabao Pharmaceutical Group
| Record | Firm | Date |
|---|---|---|
| Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus (NCT03414892) | Yabao Pharmaceutical Group | 2018-01-03 |
Track Yabao Pharmaceutical Group automatically
Every clearance here is in the API, with alerts when new ones post.